• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

英国流行戒烟辅助工具的患病率及其与戒烟成功的关联。

Prevalence of Popular Smoking Cessation Aids in England and Associations With Quit Success.

作者信息

Jackson Sarah E, Brown Jamie, Buss Vera, Shahab Lion

机构信息

Department of Behavioural Science and Health, University College London, London, United Kingdom.

SPECTRUM Consortium, United Kingdom.

出版信息

JAMA Netw Open. 2025 Jan 2;8(1):e2454962. doi: 10.1001/jamanetworkopen.2024.54962.

DOI:10.1001/jamanetworkopen.2024.54962
PMID:39821398
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11742533/
Abstract

IMPORTANCE

A wide range of medications, noncombustible nicotine products, behavioral support, and alternative treatments are available in England to help people stop smoking. Understanding their effectiveness outside of clinical trial settings can support informed decision-making.

OBJECTIVES

To provide up-to-date estimates of the prevalence of different smoking cessation aids and associations with quit success and to explore moderation by socioeconomic position.

DESIGN, SETTING, AND PARTICIPANTS: This survey study used data from the Smoking Toolkit Study, a monthly cross-sectional household survey, conducted from 2006 to 2024 in England, UK. Participants were individuals aged at least 16 years who reported trying to quit smoking in the past year. Analyses were conducted from July to November 2024.

MAIN OUTCOMES AND MEASURES

The outcome variable was self-reported success in quitting smoking from the start of the most recent quit attempt up to the time of survey (hereafter, quit success). Independent variables were use (yes or no) of the following aids in the most recent attempt: nicotine replacement therapy (NRT), obtained via prescription or over-the-counter; varenicline; bupropion; electronic cigarettes (e-cigarettes); face-to-face behavioral support; telephone support; written self-help materials; websites; smartphone apps; hypnotherapy; Allen Carr's Easyway method; heated tobacco products (HTPs); and nicotine pouches. Covariates included sociodemographic characteristics and features of the quit attempt.

RESULTS

A total of 25 094 participants (mean [SD] age, 38.7 [15.3] years; 51.5% [95% CI, 50.8%-52.2%] men) were included. In 2023 to 2024, the most used aids were e-cigarettes (40.2% [95% CI, 37.6%-42.8%]) and over-the-counter NRT (17.3% [95% CI, 15.3%-19.2%]); 40.8% (95% CI, 38.2%-43.4%) of quit attempts were unaided. While e-cigarette use was associated with higher odds of quit success after adjustment for use of other aids and covariates (odds ratio [OR], 1.95 [95% CI, 1.74-2.17]), use of over-the-counter NRT was not (OR, 1.03 [95% CI, 0.93-1.15]). Other aids positively associated with quit success were websites (used by 4.6% [95% CI, 3.5%-5.7%] in 2023-2024; OR, 1.43 [95% CI, 1.03-1.98]), prescription NRT (used by 4.5% [95% CI, 3.4%-5.5%] in 2023-2024; OR, 1.33 [95% CI, 1.12-1.58]), varenicline (used by 1.1% [95% CI, 0.5%-1.7%] in 2023-2024; OR, 1.80 [95% CI, 1.50-2.18]), and HTPs (used by 0.7% [95% CI, 0.3%-1.1%] in 2023-2024; OR, 2.37 [95% CI, 1.24-4.51]). Face-to-face behavioral support (used by 2.2% [95% CI, 1.5-2.9] in 2023-2024) was associated with higher odds of quit success among those from less advantaged (OR, 1.59 [95% CI, 1.19-2.14]) but not more advantaged (OR, 0.91 [95% CI, 0.65-1.29]) socioeconomic positions. There was not clear evidence of a benefit of any other aid, although some analyses were inconclusive.

CONCLUSIONS AND RELEVANCE

This cross-sectional study found that while a range of effective smoking cessation aids are available in England, many people tried to quit using less effective forms of support or none at all. Quit success rates could be improved by encouraging people to use more effective methods.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74df/11742533/c88572398fde/jamanetwopen-e2454962-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74df/11742533/f439b96ee53c/jamanetwopen-e2454962-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74df/11742533/c88572398fde/jamanetwopen-e2454962-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74df/11742533/f439b96ee53c/jamanetwopen-e2454962-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74df/11742533/c88572398fde/jamanetwopen-e2454962-g002.jpg
摘要

重要性

在英格兰,有多种药物、不可燃尼古丁产品、行为支持和替代疗法可帮助人们戒烟。了解它们在临床试验环境之外的有效性有助于做出明智的决策。

目的

提供不同戒烟辅助工具的流行率的最新估计以及与戒烟成功的关联,并探讨社会经济地位的调节作用。

设计、设置和参与者:这项调查研究使用了吸烟工具包研究的数据,这是一项于2006年至2024年在英国英格兰进行的每月横断面家庭调查。参与者是年龄至少16岁且报告在过去一年中尝试戒烟的个人。分析于2024年7月至11月进行。

主要结果和测量指标

结果变量是从最近一次戒烟尝试开始到调查时自我报告的戒烟成功情况(以下简称戒烟成功)。自变量是在最近一次尝试中是否使用了以下辅助工具:通过处方或非处方获得的尼古丁替代疗法(NRT)、伐尼克兰、安非他酮、电子烟、面对面行为支持、电话支持、书面自助材料、网站、智能手机应用程序、催眠疗法、艾伦·卡尔的轻松戒烟法、加热烟草产品(HTP)和尼古丁袋。协变量包括社会人口学特征和戒烟尝试的特征。

结果

共纳入25094名参与者(平均[标准差]年龄,38.7[15.3]岁;51.5%[95%置信区间,50.8%-52.2%]为男性)。在2023年至2024年,最常用的辅助工具是电子烟(40.2%[95%置信区间,37.6%-42.8%])和非处方NRT(17.3%[95%置信区间,15.3%-19.2%]);40.8%(95%置信区间,38.2%-43.4%)的戒烟尝试没有使用辅助工具。在调整了其他辅助工具的使用和协变量后,使用电子烟与戒烟成功的较高几率相关(优势比[OR],1.95[95%置信区间,1.74-2.17]),而使用非处方NRT则不然(OR,1.03[95%置信区间,0.93-1.15])。与戒烟成功呈正相关的其他辅助工具包括网站(2023-2024年有4.6%[95%置信区间,3.5%-5.7%]使用;OR,1.4

相似文献

1
Prevalence of Popular Smoking Cessation Aids in England and Associations With Quit Success.英国流行戒烟辅助工具的患病率及其与戒烟成功的关联。
JAMA Netw Open. 2025 Jan 2;8(1):e2454962. doi: 10.1001/jamanetworkopen.2024.54962.
2
Smoking cessation medicines and e-cigarettes: a systematic review, network meta-analysis and cost-effectiveness analysis.戒烟药物和电子烟:系统评价、网络荟萃分析和成本效益分析。
Health Technol Assess. 2021 Oct;25(59):1-224. doi: 10.3310/hta25590.
3
Interventions to reduce harm from continued tobacco use.减少持续吸烟危害的干预措施。
Cochrane Database Syst Rev. 2016 Oct 13;10(10):CD005231. doi: 10.1002/14651858.CD005231.pub3.
4
Pharmacological and electronic cigarette interventions for smoking cessation in adults: component network meta-analyses.药物和电子烟干预成人戒烟的效果:成分网络荟萃分析。
Cochrane Database Syst Rev. 2023 Sep 12;9(9):CD015226. doi: 10.1002/14651858.CD015226.pub2.
5
Nicotine receptor partial agonists for smoking cessation.尼古丁受体部分激动剂用于戒烟。
Cochrane Database Syst Rev. 2023 May 5;5(5):CD006103. doi: 10.1002/14651858.CD006103.pub8.
6
Nicotine receptor partial agonists for smoking cessation.用于戒烟的尼古丁受体部分激动剂。
Cochrane Database Syst Rev. 2016 May 9;2016(5):CD006103. doi: 10.1002/14651858.CD006103.pub7.
7
Electronic cigarettes for smoking cessation.电子烟戒烟。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD010216. doi: 10.1002/14651858.CD010216.pub7.
8
Interventions for tobacco use cessation in people living with HIV.HIV 感染者的戒烟干预措施。
Cochrane Database Syst Rev. 2024 Aug 5;8(8):CD011120. doi: 10.1002/14651858.CD011120.pub3.
9
Pharmacological interventions for smoking cessation: an overview and network meta-analysis.戒烟的药物干预:综述与网状Meta分析
Cochrane Database Syst Rev. 2013 May 31;2013(5):CD009329. doi: 10.1002/14651858.CD009329.pub2.
10
Nicotine replacement therapy for smoking cessation.用于戒烟的尼古丁替代疗法。
Cochrane Database Syst Rev. 2012 Nov 14;11:CD000146. doi: 10.1002/14651858.CD000146.pub4.

本文引用的文献

1
A taste of Nordic freedom: The problematic marketing of nicotine pouches in the United Kingdom.体验北欧式自由:英国尼古丁小烟袋的问题营销。
Nordisk Alkohol Nark. 2024 Dec;41(6):574-598. doi: 10.1177/14550725241270227. Epub 2024 Sep 3.
2
Impact of the disruption in supply of varenicline since 2021 on smoking cessation in England: A population study.自 2021 年以来伐伦克林供应中断对英国戒烟的影响:一项人群研究。
Addiction. 2024 Jul;119(7):1203-1210. doi: 10.1111/add.16485. Epub 2024 Apr 30.
3
Electronic Nicotine-Delivery Systems for Smoking Cessation.
电子尼古丁传送系统在戒烟中的应用。
N Engl J Med. 2024 Feb 15;390(7):601-610. doi: 10.1056/NEJMoa2308815.
4
Electronic cigarettes for smoking cessation.电子烟戒烟。
Cochrane Database Syst Rev. 2024 Jan 8;1(1):CD010216. doi: 10.1002/14651858.CD010216.pub8.
5
Pharmacological and electronic cigarette interventions for smoking cessation in adults: component network meta-analyses.药物和电子烟干预成人戒烟的效果:成分网络荟萃分析。
Cochrane Database Syst Rev. 2023 Sep 12;9(9):CD015226. doi: 10.1002/14651858.CD015226.pub2.
6
Effectiveness of eHealth Smoking Cessation Interventions: Systematic Review and Meta-Analysis.电子健康戒烟干预措施的有效性:系统评价和荟萃分析。
J Med Internet Res. 2023 Jul 28;25:e45111. doi: 10.2196/45111.
7
Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation.不同剂量、持续时间和尼古丁替代疗法给药方式对戒烟的效果。
Cochrane Database Syst Rev. 2023 Jun 19;6(6):CD013308. doi: 10.1002/14651858.CD013308.pub2.
8
Antidepressants for smoking cessation.抗抑郁药戒烟。
Cochrane Database Syst Rev. 2023 May 24;5(5):CD000031. doi: 10.1002/14651858.CD000031.pub6.
9
Nicotine receptor partial agonists for smoking cessation.尼古丁受体部分激动剂用于戒烟。
Cochrane Database Syst Rev. 2023 May 5;5(5):CD006103. doi: 10.1002/14651858.CD006103.pub8.
10
The Effectiveness of Smartphone App-Based Interventions for Assisting Smoking Cessation: Systematic Review and Meta-analysis.基于智能手机应用程序的干预措施在协助戒烟方面的有效性:系统评价和荟萃分析。
J Med Internet Res. 2023 Apr 20;25:e43242. doi: 10.2196/43242.